Search This Blog

Tuesday, December 3, 2019

KalVista Pharmaceticals EPS beats by $0.22, beats on revenue

KalVista Pharmaceticals (NASDAQ:KALV): Q2 GAAP EPS of -$0.33 beats by $0.22.
Revenue of $3.92M (-29.9% Y/Y) beats by $0.65M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)